Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSTONE PHARMA-B

7.170
-0.350-4.65%
Volume:9.12M
Turnover:65.74M
Market Cap:10.50B
PE:-91.83
High:7.610
Open:7.610
Low:7.070
Close:7.520
Loading ...
OverviewCompanyNewsFilings

Company Profile

Company Name:
CSTONE PHARMA-B
Exchange:
SEHK
Establishment Date:
2015
Employees:
135
Office Location:
C1 Building,No. 218 Xinghu Street,North Block,Suzhou Industrial Park,Suzhou,Jiangsu Province,China
Website:
http://www.cstonepharma.com
Zip Code:
215123
Phone:
86 512 8718 6550
Fax:
- -
Introduction:
CStone Pharmaceuticals is a biopharmaceutical investment holding company focused on the research and development of anti-cancer therapies. Through its subsidiaries, the Company is primarily engaged in the research and development of biopharmaceutical products, sale of pharmaceutical products and provision of license of its intellectual property (IP) or commercialization license. The Company’s main products include targeted therapies, AYVAKIT (avapritinib) and GAVRETO (pralsetinib). The Company is also involved in the development and commercialization of immuno-oncology. The Company mainly conducts its businesses in the domestic market and overseas markets, such as Central and Eastern Europe and Switzerland.

Directors

Name
Position
LI Wei
Chairman of the Board,Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
Jason Yang
Executive Director,Chairman of the Strategic and Development Committee
WU Ting Yuk Anthony
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
Betty Yip Ho
Independent Director,Member of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Investment Decision Committee Member,Audit Committee Chairman
Edward Hu
Director,Member of the Strategic and Development Committee,Investment Decision Committee Chairman
Kenneth Walton Hitchner III
Director,Investment Decision Committee Member

Shareholders

Name
Position
Jason Yang
CEO,Other Senior Executives
SHI Qing Mei
Vice General Manager,Other Senior Executives
ZHANG Ying Hua
Vice General Manager,Other Senior Executives
NI Wei Cong
CFO,Board Secretary,Corporate Secretary
WENG Mei Yi
Corporate Secretary
Michael J. Choi
Chief Business Officer,Other Senior Executives
LA Yu Juan
Other Senior Executives